The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

På svenska

Author

  • Frank Wegmann
  • Kate H. Gartlan
  • Ali M. Harandi
  • Sarah A. Brinckmann
  • Margherita Coccia
  • William R. Hillson
  • Wai Ling Kok
  • Suzanne Cole
  • Ling-Pei Ho
  • Teresa Lambe
  • Manoj Puthia
  • Catharina Svanborg
  • Erin M. Scherer
  • George Krashias
  • Adam Williams
  • Joseph N. Blattman
  • Philip D. Greenberg
  • Richard A. Flavell
  • Amin E. Moghaddam
  • Neil C. Sheppard
  • Quentin J. Sattentau
Show all

Summary, in English

Protection against mucosally transmitted infections probably requires immunity at the site of pathogen entry(1), yet there are no mucosal adjuvant formulations licensed for human use. Polyethyleneimine (PEI) represents a family of organic polycations used as nucleic acid transfection reagents in vitro and DNA vaccine delivery vehicles in vivo(2,3). Here we show that diverse PEI forms have potent mucosal adjuvant activity for viral subunit glycoprotein antigens. A single intranasal administration of influenza hemagglutinin or herpes simplex virus type-2 (HSV-2) glycoprotein D with PEI elicited robust antibody-mediated protection from an otherwise lethal infection, and was superior to existing experimental mucosal adjuvants. PEI formed nanoscale complexes with antigen, which were taken up by antigen-presenting cells in vitro and in vivo, promoted dendritic cell trafficking to draining lymph nodes and induced non-proinflammatory cytokine responses. PEI adjuvanticity required release of host double-stranded DNA that triggered Irf3-dependent signaling. PEI therefore merits further investigation as a mucosal adjuvant for human use.

Publishing year

2012

Language

English

Pages

883-888

Publication/Series

Nature Biotechnology

Volume

30

Issue

9

Document type

Journal article

Publisher

Nature Publishing Group

Topic

  • Microbiology in the medical area
  • Immunology in the medical area

Status

Published

ISBN/ISSN/Other

  • ISSN: 1546-1696